Our technology

Unlocking biological insights from biofluids.

We develop advanced biomarker technologies that turn accessible biological samples into meaningful molecular information, by studying extracellular vesicles (EVs) isolated from biofluids.

From brain to sample: extracellular vesicles carry brain-derived signals into an accessible biofluid

Biofluids

A new window into human biology

Biological fluids contain extracellular vesicles that carry molecular information from many different cells and tissues.

By accessing these signals, MedPrecis aims to bridge the gap between molecular mechanisms and clinically relevant biological information.

Our platform profiles biologically relevant EV populations (including, but not limited to, brain-derived vesicles) combining selective enrichment with protein and microRNA analysis.

From brain to blood

A brain signal in a simple blood sample

Brain cells (neurons, astrocytes and microglia) continuously release extracellular vesicles. Some of them cross the blood–brain barrier and circulate in the blood.

Each vesicle carries proteins, microRNA and markers of the cell it came from: a molecular snapshot of brain biology, from a simple blood sample.

Neuron Astrocyte Microglia Brain-derived vesicles Simple blood sample Proteins microRNA Surface markers of the cell of origin Lipid membrane One vesicle, a molecular snapshot Brain Blood Blood–brain barrier
Extracellular vesicles Applications Our approach Psychiatry Neurodegeneration Oncology Systemic health Biofluids EV enrichment Proteins & microRNA Interpretation

At a glance

Extracellular vesicles: messengers from every organ

Released by cells throughout the body, extracellular vesicles reflect the state of the tissues they come from.

Our approach (from biofluid sample to vesicle enrichment, protein and microRNA analysis and interpretation) supports research in psychiatry, neurodegeneration, oncology and systemic health.

From sample to insight

One platform. Multiple biological dimensions.

A simple, four-stage approach that turns a biofluid sample into interpretable molecular information.

01

Biofluid collection

Accessible biological samples, such as blood-derived plasma and serum, are the starting point of our investigations.

02

Selective EV enrichment

Our proprietary workflow enriches biologically relevant vesicle populations from the sample.

03

Molecular profiling

Vesicle-associated proteins and microRNAs are analysed together for complementary information on disease-related pathways.

04

Biological interpretation

Results support the study of biological mechanisms, biomarker signatures and differences between patients.

Our scientific advantage

Beyond conventional biomarkers

Tissue-relevant information

Access molecular signals associated with specific tissues and cell populations through enriched vesicles.

Mechanism-oriented profiling

Study the biological pathways involved in disease, beyond conventional clinical classifications alone.

Multidimensional analysis

Combine complementary protein and microRNA information to explore disease-associated molecular signatures.

Standardised workflows

Structured procedures and quality-control practices designed for reliable, traceable measurements.

Applications

Enabling the next generation of precision medicine

Biomarker discovery

Identify and investigate molecular signatures associated with disease states and biological processes.

Patient stratification

Explore biologically informed patient subgroups to support precision-oriented research.

Clinical research

Support exploratory and translational biomarker studies within clinical research programmes.

Therapeutic development

Investigate disease mechanisms and molecular responses to therapeutic interventions.

Scientific foundation

Built on translational research

MedPrecis builds on research connecting molecular mechanisms, extracellular-vesicle biology and human disease.

Our technology is supported by research expertise, scientific publications and collaborations with academic and clinical institutions.

We aim to translate advances in molecular neuroscience into scalable biomarker applications for research and therapeutic development.

Partner with MedPrecis

Advancing precision medicine together

We work with pharmaceutical companies, biotech innovators, academic institutions and clinical research teams to advance biomarker-driven research.

Whether you are planning a clinical study, investigating therapeutic mechanisms or exploring new biomarker strategies, we can contribute specialised analytical expertise.

Working on a study or manuscript?

Further validated assay specifications and performance characteristics can be shared with collaborators where needed for reproducibility, while protecting our proprietary technology.